MARKET

IMMX

IMMX

Immix Biopharma Inc
NASDAQ
8.07
-0.59
-6.81%
After Hours: 8.33 +0.26 +3.22% 19:30 11/12 EST
OPEN
8.40
PREV CLOSE
8.66
HIGH
8.50
LOW
8.06
VOLUME
960.30K
TURNOVER
--
52 WEEK HIGH
15.10
52 WEEK LOW
3.160
MARKET CAP
670.45M
P/E (TTM)
-9.3112
1D
5D
1M
3M
1Y
5Y
1D
Immix Biopharma reports Q3 results
Seeking Alpha · 10h ago
Immix Biopharma Q3 EPS $(0.19), Inline
Benzinga · 11h ago
Press Release: Immix Biopharma Reports Third Quarter 2026 Financial Results and Update on Corporate Progress
Dow Jones · 12h ago
Press Release: Immix Biopharma Reports Third -2-
Dow Jones · 12h ago
IMMX's Cash Runway Now Extends Exactly as Far as Its Promises Do
Barchart · 17h ago
Weekly Report: what happened at IMMX last week (1102-1106)?
Weekly Report · 3d ago
Immix Biopharma To Present An NXC-201 Abstract At American Society Of Hematology Annual Meeting, December 12-15
Benzinga · 11/04 14:18
Weekly Report: what happened at IMMX last week (1026-1030)?
Weekly Report · 11/02 10:23
More
About IMMX
Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the application of chimeric antigen receptor cell therapy (CAR- T) in light chain (AL) Amyloidosis and select immune-mediated diseases. The Company's lead cell therapy candidate CAR-T NXC-201 (NXC-201), which is being evaluated in its ongoing United States Phase Ib/II NEXICART-2 (NCT06097832) clinical trial. Its lead program, NXC-201 is a next generation CAR-T targeting B-cell maturation antigen. CAR-T cell therapy is a type of immunotherapy that uses the patient’s own immune cells, modified with its proprietary technology. Its N-GENIUS cell engineering platform with EXPAND technology has produced clinical-stage CAR-T NXC-201, targeting B cell maturation antigen, which is autologous CAR-T being developed to treat AL Amyloidosis.

Webull offers Immix Biopharma Inc stock information, including NASDAQ: IMMX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMMX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMMX stock methods without spending real money on the virtual paper trading platform.